|
🐜
|
Reducing inter-observer variability and interaction time of MR liver volumetry by combining automatic CNN-based liver segmentation and manual corrections
7 auth.
G. Chlebus,
H. Meine,
S. Thoduka,
N. Abolmaali,
B. van Ginneken,
H. Hahn,
...
A. Schenk
|
5 |
2019 |
5
🐜
|
|
🐬
|
Multimodal image registration for liver radioembolization planning and patient assessment
Nadine Spahr,
S. Thoduka,
N. Abolmaali,
R. Kikinis,
A. Schenk
|
3 |
2018 |
3
🐬
|
|
🐜
|
Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020
12 auth.
L. Flegar,
S. Thoduka,
D. Librizzi,
M. Luster,
A. Zacharis,
H. Heers,
...
N. Eisenmenger,
H. Ahmadzadehfar,
M. Eiber,
W. Weber,
C. Groeben,
J. Huber
|
2 |
2023 |
2
🐜
|
|
🐜
|
Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape
10 auth.
L. Flegar,
S. Thoduka,
A. Mahnken,
J. Figiel,
H. Heers,
Cem Aksoy,
...
N. Eisenmenger,
C. Groeben,
J. Huber,
A. Zacharis
|
2 |
2023 |
2
🐜
|
|
🐬
|
Predictive SIRT dosimetry based on a territorial model
Nadine Spahr,
P. Schilling,
S. Thoduka,
N. Abolmaali,
A. Schenk
|
2 |
2017 |
2
🐬
|
|
🐜
|
Trends in kidney transplantation and living donor nephrectomy in Germany: a total population analysis from 2006 to 2021
10 auth.
Aristeidis Zacharis,
Philipp Reimold,
Cem Aksoy,
Jonas Jung,
Thomas Martin,
N. Eisenmenger,
...
S. Thoduka,
C. Groeben,
Johannes Huber,
L. Flegar
|
2 |
2024 |
2
🐜
|
